|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn955129801 |
003 |
OCoLC |
005 |
20231120112126.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
160805s2016 enk o 001 0 eng d |
010 |
|
|
|a 2017287347
|
040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d YDXCP
|d N$T
|d EBLCP
|d OPELS
|d OCLCF
|d OCLCQ
|d N$T
|d OCLCQ
|d QCL
|d OCLCQ
|d DEBBG
|d COO
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d OCLCA
|d U3W
|d OCLCA
|d D6H
|d OCLCO
|d AU@
|d OCLCO
|d WYU
|d OCLCO
|d OCLCA
|d OCLCQ
|d VT2
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 957521928
|a 957954060
|a 958096130
|a 958350667
|a 960901898
|a 961151656
|a 961310822
|a 962254122
|a 962433888
|a 964291570
|a 964614647
|a 965140389
|a 966298028
|a 1066416099
|a 1235835789
|
020 |
|
|
|a 0128051477
|q (electronic bk.)
|
020 |
|
|
|a 9780128051474
|q (electronic bk.)
|
020 |
|
|
|z 9780128048320
|
020 |
|
|
|z 0128048328
|
035 |
|
|
|a (OCoLC)955129801
|z (OCoLC)957521928
|z (OCoLC)957954060
|z (OCoLC)958096130
|z (OCoLC)958350667
|z (OCoLC)960901898
|z (OCoLC)961151656
|z (OCoLC)961310822
|z (OCoLC)962254122
|z (OCoLC)962433888
|z (OCoLC)964291570
|z (OCoLC)964614647
|z (OCoLC)965140389
|z (OCoLC)966298028
|z (OCoLC)1066416099
|z (OCoLC)1235835789
|
050 |
|
4 |
|a RC523
|
060 |
|
4 |
|a WT 155
|b K45b 2016
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8/3104
|2 23
|
100 |
1 |
|
|a Khan, T. K.
|
245 |
1 |
0 |
|a Biomarkers in Alzheimer's disease /
|c T.K. Khan.
|
260 |
|
|
|a London, United Kingdom :
|b Academic Press :
|b Elsevier,
|c 2016.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover ; Title page; Copyright page; Contents; Foreword; Preface; Acknowledgments; Chapter 1 -- Introduction to Alzheimer's Disease Biomarkers ; 1.1 -- Historical Background; 1.2 -- Important Events in Alzheimer's Disease (AD) Research; 1.3 -- Some Facts About Alzheimer's Disease; 1.4 -- Common Features of Alzheimer's Disease; 1.5 -- Classification of Alzheimer's Disease; 1.6 -- Risk Factors for Alzheimer's Disease; 1.7 -- Definition of a Biomarker; 1.7.1 -- A. Categorization of Biomarkers According to Their Role.
|
505 |
8 |
|
|a 1.7.2 -- B. Definition of Common Statistical Parameters to Quantify the Performance of Biomarkers1.8 -- Biomarkers of Alzheimer's Disease; 1.9 -- Future Focus: Detecting Preclinical Stages of Alzheimer's Disease; 1.10 -- Economic Impact of Alzheimer's Disease Biomarkers; 1.11 -- Conclusions; Bibliography; Chapter 2 -- Clinical Diagnosis of Alzheimer's Disease ; 2.1 -- Clinical Diagnosis of Alzheimer's Disease: Historical Perspective; 2.2 -- Neuropsychological Assessment Tests to Diagnose Alzheimer's Disease; 2.2.1 -- Mini-Mental State Examination; 2.2.2 -- Clock Drawing Test.
|
505 |
8 |
|
|a 2.2.3 -- Alzheimer's Disease Assessment Scale2.2.4 -- Neuropsychological Test Battery; 2.2.4.1 -- Other neuropsychological tests; 2.2.5 -- Clinical Dementia Rating; 2.2.6 -- Global Deterioration Scale; 2.2.7 -- Dementia Severity Rating Scale; 2.3 -- Neuropathology at Brain Autopsy to Diagnose Alzheimer's Disease; 2.4 -- Accuracy of Clinical Diagnosis of Alzheimer's Disease; 2.5 -- Alzheimer's Disease-Related Neurological Conditions; 2.5.1 -- Preclinical Alzheimer's Disease; 2.5.2 -- Mild Cognitive Impairment; 2.5.3 -- Non-Alzheimer's Dementias; 2.5.3.1 -- Vascular dementia; 2.5.3.2 -- Lewy body dementia.
|
505 |
8 |
|
|a 2.5.3.3 -- Frontotemporal dementia2.5.3.4 -- Creutzfeldt-Jacob disease; 2.5.3.5 -- Other non-AD dementias; 2.6 -- Challenges in Diagnosing Alzheimer's Disease; 2.6.1 -- Long Prodromal Stages; 2.6.2 -- Comorbidity With Non-Alzheimer's Disease Dementias; 2.6.3 -- Multiple Nongenetic and Genetic Factors; 2.6.4 -- Anomalous Alzheimer's Disease Neuropathology; 2.7 -- Comprehensive Alzheimer's Disease Diagnostic Framework; 2.8 -- Conclusions; Bibliography; Chapter 3 -- Neuroimaging Biomarkers in Alzheimer's Disease ; 3.1 -- Neuroimaging in Alzheimer's Disease; 3.1.1 -- Structural Neuroimaging.
|
505 |
8 |
|
|a 3.1.2 -- Functional Neuroimaging3.1.3 -- Molecular Neuroimaging; 3.2 -- Common Neuroimaging Alzheimer's Disease Biomarkers and Modalities; 3.3 -- Magnetic Resonance Imaging; 3.3.1 -- Structural MRI; 3.3.2 -- Functional MRI; 3.3.3 -- Magnetic Resonance Spectroscopy; 3.3.4 -- Advanced Magnetic Resonance Based Neuroimaging Modalities; 3.3.4.1 -- Diffusion tensor imaging; 3.3.4.2 -- Arterial spin labeling MRI; 3.3.4.3 -- Task free fMRI; 3.4 -- Positron Emission Tomography; 3.4.1 -- Amyloid Imaging by PET; 3.4.2 -- Glucose Metabolism Measurement by PET; 3.4.3 -- Brain Inflammation Imaging by PET.
|
505 |
8 |
|
|a 3.4.4 -- Tau Imaging by PET.
|
500 |
|
|
|a Includes index.
|
504 |
|
|
|a Includes bibliographical references and index.
|
650 |
|
0 |
|a Alzheimer's disease
|x Molecular aspects.
|
650 |
|
0 |
|a Biochemical markers.
|
650 |
|
2 |
|a Alzheimer Disease
|x diagnosis
|0 (DNLM)D000544Q000175
|
650 |
|
2 |
|a Biomarkers
|0 (DNLM)D015415
|
650 |
|
6 |
|a Maladie d'Alzheimer
|0 (CaQQLa)201-0114128
|x Aspect mol�eculaire.
|0 (CaQQLa)201-0374959
|
650 |
|
6 |
|a Marqueurs biologiques.
|0 (CaQQLa)201-0177920
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Alzheimer's disease
|x Molecular aspects
|2 fast
|0 (OCoLC)fst00806550
|
650 |
|
7 |
|a Biochemical markers
|2 fast
|0 (OCoLC)fst00831950
|
776 |
0 |
8 |
|i Erscheint auch als:
|n Druck-Ausgabe
|t Khan, Tapan. Biomarkers in Alzheimer's Disease
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128048320
|z Texto completo
|